US Patent Issued to VeonGen Therapeutics on June 16 for "Method of transactivating a homologous gene of a gene of interest and an in vitro method of diagnosing a disease" (German Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,908, issued on June 16, was assigned to VeonGen Therapeutics GmbH (Planegg, Germany).

"Method of transactivating a homologous gene of a gene of interest and an in vitro method of diagnosing a disease" was invented by Stylianos Michalakis (Munich), Elvir Becirovic (Munich), Lisa Riedmayr (Munich), Victoria Splith (Munich), Sybille Bohm (Munich) and Martin Biel (Starnberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of trans-activating a homologous gene of at least one gene of interest and optionally deactivation of at least one gene of interest, wherein the mRNA encoded by the at least one gene of ...